Management of Premenstrual Disorders

Anisha Nakulan

Abstract


The impact of premenstrual disorders(PMDs) on women’s lives is largely under-recognized. Inconsistent diagnostic guidelines and poor evidence base for effective treatment strategies lead to inadequate management. The diagnostic categories as per the Consensus Group of the International Society for Premenstrual Disorders (ISPD) divide PMDs to Core PMDs and Variant PMDs and can be clinically useful.  Non-pharmacological methods like exercise, dietary modifications and cognitive behavioral therapy may be used for PMDs associated with mild distress, but the evidence base remains inadequate. Evidence indicates that that serotonin re-uptake inhibitors citalopram, escitalopram, fluoxetine, paroxetine and sertraline, and the serotonin and noradrenaline reuptake inhibitor venlafaxine are effective for severe PMDs.


Full Text:

PDF

References


Frank RT. The hormonal causes of premenstrual tension. Arch Neur Psych 1931;26(5):1053–7.

American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Text revision (DSM-IV-TR). Fourth edition. Washington, DC: American Psychiatric Association; 2000. p. 771–4.

Epperson CN, Steiner M, Hartlage SA, Eriksson E, Schmidt PJ, Jones I, et al. Premenstrual Dysphoric Disorder: Evidence for a new category for DSM-5. Am J Psychiatry 2012;169(5):465–75.

Halbreich U. The diagnosis of premenstrual syndromes and premenstrual dysphoric disorder—clinical procedures and research perspectives. Gynecol Endocrinol 2004; 19:320–34.

Freeman EW, Sondheimer SJ. Premenstrual dysphoric disorder: recognition and treatment. Prim Care Companion J Clin Psychiatry 2003; 5:30–9.

World Health Organization. International statistical classification of diseases and related health problems. 10th. Geneva: 2004.

ACOG. ACOG practice bulletin: premenstrual syndrome. Int J Gynecol Obstet 2001; 73:183–91.

American Psychiatric Association. Diagnostic and Statistical Manual of mental disorders (5th ed.). 5th ed. American Psychiatric Publishing; Arlington: 2013

Endicott J, Nee J, Harrison W. Daily record of severity of problems (DRSP): reliability and validity. Arch Womens Ment Health 2006; 9:41–9.

Feuerstein M, Shaw WS. Measurement properties of the calendar of premenstrual experience in patients with premenstrual syndrome. J Reprod Med 2002; 47:279–89.

Allen SS, McBride CM, Pirie PL. The shortened premenstrual assessment form. J Reprod Med 1991; 36:769–72.

O'Brien PMS, Bäckström T, Brown C, Dennerstein L, Endicott J, Epperson CN, et al. Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensus. Arch Womens Ment Health 2011; 14:13–21.

Case AM, Reid RL. Effects of the menstrual cycle on medical conditions. Arch Intern Med 1998; 158:1405–12.

Schmidt PJ, Nieman LK, Danaceau MA, Adams LF, Rubinow DR. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N Engl J Med 1998; 338:209–16.

Robinson LL, Ismail KM. Clinical epidemiology of premenstrual disorder: informing optimized patient outcomes. Int J Womens Health 2015; 7:811-18.

Wittchen HU, Becker E, Lieb R, Krause P. Prevalence, incidence and stability of premenstrual dysphoric disorder in the community. Psychol Med 2002; 32(01):119-32.

Pearlstein T, Steiner M. Premenstrual dysphoric disorder: burden of illness and treatment update. J Psychiatry Neurosci 2008; 33(4):291-301.

Yonkers KA, O'Brien PS, Eriksson E. Premenstrual syndrome. Lancet 2008; 371(9619):1200-10.

Vigod SN, Frey BN, Soares CN, Steiner M. Approach to premenstrual dysphoria for the mental health practitioner. Psychiatr Clin North Am 2010; 33(2):257-72.

Yang M, Wallenstein G, Hagan M,Guo A, Chang J, Kornstein S. Burden of premenstrual dysphoric disorder on health-related quality of life. J Womens Health 2008; 17(1):113–21.

Richards M, Rubinow DR, Daly RC, Schmidt PJ. Premenstrual symptoms and perimenopausal depression. Am J Psychiatry 2006; 163:133–7.

Studd JWW, Smith RNJ. Estrogens and depression in women. Menopause: J North Am Menopause Soc 1994; 1:33–7.

Bloch M, Schmidt PJ, Danaceau M, Murphy J, Nieman L, Rubinow DR. Effects of gonadal steroids in women with a history of postpartum depression. Am J Psychiatry 2000; 157:924–30.

Borenstein JE, Dean BB, Yonkers KA, Endicott J. Using the daily record of severity of problems as a screening instrument for premenstrual syndrome. Obstet Gynecol 2007; 109:1068–75.

Royal College of Obstetricians and Gynaecologists (RCOG). Management of Premenstrual Syndrome (Green-top Guideline No. 48). 2007.

ACOG: ACOG Practice Bulletin. Premenstrual syndrome. Clinical management guidelines for obsetrician-gynecologists. Int J Obstet Gynecol 2001; 73:183–91.

Wyatt KM, Dimmock PW, O’Brien PMS. Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database of Syst Rev 2003; 3:CD001396.

Yonkers KA, Clark RH, Trivedi MH. The psychopharmacological treatment of non-major mood disorders. In: Rush AJ, editor. Mood disorders: systematic medication management— modern problems of pharmacopsychiatry. 2nd ed. Basel: Karger; 1997. p. 146-66.

Hantsoo L, Epperson CN. Premenstrual dysphoric disorder: epidemiology and treatment. Curr Psychiatry Rep 2015;17(11):1-9.

Jarvis, Courtney I., Ann M. Lynch, and Anna K. Morin. Management strategies for premenstrual syndrome/premenstrual dysphoric disorder. Ann of Pharmacother 2008; 42(7-8): 967-78.

Luisi AF, Pawasauskas JE. Treatment of premenstrual dysphoric disorder with selective serotonin reuptake inhibitors. Pharmacotherapy 2003; 23:1131-40.

Nevatte T, O’Brien PM, Bäckström T, Brown C, Dennerstein L, Endicott J, et al. ISPMD consensus on the management of premenstrual disorders. Arch Womens Ment Health 2013; 16(4):279-91.

Cunningham J, Yonkers KA, O'Brien S, Eriksson E. Update on research and treatment of premenstrual dysphoric disorder. Harv Rev Psychiatry 2009; 17(2):120-37.

Busse JW, Montori VM, Krasnik C, Patelis-Siotis I, Guyatt GH. Psychological intervention for premenstrual syndrome: a meta-analysis of randomized controlled trials. Psychother Psychosom 2009; 78:6–15.

Lustyk MK, Gerrish WG, Shaver S, Keys SL. Cognitive–behavioral therapy for premenstrual syndrome and premenstrual dysphoric disorder: a systematic review. Arch Womens Ment Health 2009; 12:85–96.

Daley A. Exercise and premenstrual symptomatology: a comprehensive review. J Womens Health 2009;18(6):895-9.


Refbacks

  • There are currently no refbacks.




Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Print ISSN: 0377-0699 Online ISSN: 2395-1486